In our advocacy for more and better financing for health, we find it important that the call for adequately funding Universal Health Coverage (UHC) takes on board the lessons learned on funding for HIV. Therefore, Wemos worked together with STOPAIDS members, allies and partners on this factsheet on UHC and HIV, which was disseminated at the High-Level Meeting on UHC earlier this week.
A well-balanced debate on fair drug prices in Brussels is still being obstructed on all sides by the continuous pharma lobby, reports EU correspondent Lise Witteman from Follow The Money. For her research article, one of the people she spoke with was our global health advocate Ella Weggen
The issue of creating jobs in a decent and fair way is one of the most pressing global challenges of our era. This is Vice Versa’s – journalism platform on global development – main message of their special jobs report “The World of Work”, published last week. Our director Mariëlle Bemelmans highlights the specific concerns related to this urgent and complex dilemma for the health care sector: “Governments and donors need to realize the importance of investing in healthcare, including the creation of employment opportunities.”
This week Devex – a media platform for the global development community – explores the question whether governments should see health care as an ‘investment’. One of the people who comment on this matter, is our global health advocate Mariska Meurs. She talks about health financing and achieving Universal Health Coverage, from a rights-based approach. “Reorienting the health funding discourse around human rights may also be economically beneficial, as it disentangles health financing from politics.”
Wemos’ four new papers are part of a series about the Global Financing Facility (GFF) at national level and show the GFF process in Kenya, Malawi, Tanzania and Uganda.
With great enthusiasm and pride we welcomed many to our 40th anniversary congress ‘Global Health, everybody’s concern and everybody’s business, in COMM in The Hague last Friday. With various attendees – from our co-founders and partner organisations, to policy makers and students – we discussed 40 years of advocating the right to health worldwide, the current changes in the global health landscape and of course, the challenges ahead. What an inspiring day!
Wemos critically follows the developments and outcomes of the Global Financing Facility (GFF) for Reproductive, Maternal, Newborn, Child and Adolescent Health. In a new interactive story, we tell about our efforts to create space for civil society engagement in the GFF, to influence and improve this global health initiative.
“This lawsuit is of great significance. This is the first time a health insurer in the Netherlands has filed a lawsuit against a pharmaceutical company for incorrectly adhering to a patent.” This is what global health advocate Ella Weggen said in the programme EenVandaag, about the ruling of the trial Menzis vs. AstraZeneca, which has been scheduled for June 24th [editor note: update May 2020 – see below].